Member Info for ratcliffewriter

...and more in fact.

There was me thinking you were sending smiles because you'd hidden a sausage somewhere.

Indeed so. Pork id that he is.

The worm is positively spinning - who'd think that 'you're onto a winner here' was written by the same poster who very recently wrote

'So whilst this is a good punt ,don’t fall in love with Val Stephen as there’s still a big loss to come this year and next and my gut (and it’s a big one !!) tells me that shareholders and bucket shop brokers won’t back any more fund raises here.'

BTW porky you have saved many a fortune so thank you.

And also 'Pm (aka as MT imho ) you are a disgrace ,you’ve cost investors a fortune.'

Just for detail the 401 extension was for 6 months from 20th November 2024. So the clock counts down to 20th May on this next graspable straw. 6 weeks or so.....tick tock tick tock....

Mind you, I'm surprised PM and his little team haven't started cranking up 401 yet. The RNS said '...

further to the exclusive Option Agreement announced on 5 December 2023 between ValiSeek Limited ("ValiSeek") and Ambrose Healthcare Limited ("Ambrose Healthcare"), the Company has received notification from Ambrose Healthcare to exercise a six month extension to the option period granted to it under the original agreement (the "Extension").

Under the Extension, Ambrose Healthcare has a further 6-month period of exclusivity under which it may exercise the option to execute a global, exclusive license of Valiseek's VAL401 asset under pre-agreed terms.'

So yet another extension is coming to an end - time to get pumping in anticipation of a new fund raising effort maybe? 201 is deader than a Norwegian Blue, so maybe time to see if 401 can turn a trick. After all those salaries won't pay themselves will they?

'Is a bidding war about to start?' - ermm.........no.

Not a snowball's chance in hell.

Reading your informed reply convinces me that a flock of unicorns are about to fly past under the ninth blue moon this month.

...or ME will make a loss to set against his tax bill. Don't forget his salary is a consistent return on his 'investment' in VAL.

That spell checker is annoying. It wrote 'before news drops' when presumably you meant 'price drops.'

'As for 201 the hope was a big rise from 0.65 but this news might slow that down in the short term.'

Meanwhile, hopes of Tutankhamen coming back to life have suffered a setback as doctors acknowledge his heart has not been heard beating for several thousand years, but Professor PM2022 said he was hopeful of a complete recovery in due course and feels it likely that King Tut will compete in next year's London Marathon. 'If all goes as I hope, there's no reason why he can't win, and if it's in a new record time then worldwide recognition could be a certainty' said the professor from within his padded cell.

I suspect 201 will now be repurposed to turn lead into gold.

That's not what you were pushing on 25th March - you said "Obviously TheoremRx and the Nasdaq merger company will need as much details as possible to help complete the merger if 201 is the main part of that. No progress means no discussions. Likely linked."

From 'Complete the merger' to 'not priced in'?

Mind you, a week and a half is pretty much ancient history in ramperworld I suppose.

I just hope there weren't too many people suckered in by PM2022 and his acolytes while P9 and others were ringing very audible alarm bells.

Anyway I presume PM2022 will be along in a bit to tell us why this morning's RNS is actually a good thing...

Waiting for news, but unfortunately Godot is the bearer thereof.

I imagine scinv will be down your throat pretty soon as well Chester. It seems anyone who points out the absence of the word 'poster' is a 'brain dead spoon.' So much for reasoned discussion!

As I read the RNS, this is a presentation, rather than just a poster as in February, so updated data I hope. Maybe scinv's snivelling derision is a little more trivial than usual.

Dom - If you're after a career in standup you'll have to find some newer material than that.

Get a few posts up, keep pushing anything cautionary down the list.

AIM thrives on people being dazzled by the prospect of imminent riches and massive multiples of an initial investment being moments away. Pushing that is an army of 'knowledgeable' people who will kid you they are already invested and the company in question is on the cusp of stellar success. Within that are others who are either massive suckers for the hype or long term devious types who repeat the patently hollow promises of success. It's usually impossible to distinguish one from the other - perhaps PM2022 could take a long hard look and come clean on his real position?

The best way is first and foremost to put in no more than one can afford to lose - so obvious, and yet so easy to overlook if you think you have somehow stumbled on the Holy Grail ahead of everyone else. Don't blame yourselves - it's human nature. But as a one-off example, when you have people trying to sing the praises of a compound that had a very mild effect in a very very small number of patients, and has since had absolutely no commercial or institutional interest in almost 5 years, just sit back and consider whether the praise singers are genuine, or are just trying to sucker in the well meaning innocents for their own financial gain. And that's just 201.

Apply the same template to the rest of this show. It doesn't look promising in the slightest. In fact quite the opposite in my opinion and experience. Remember John Gilchrist, and if you don't remember him, then ask. It could save you a lot more than mere money.